Prognostic evaluation of severe sepsis and septic shock: Procalcitonin clearance vs δ Sequential Organ Failure Assessment

Journal of Critical Care

Volumn 30, Issue 1, 2015, Pages 219.e9-219.e12

  de Azevedo, José R A ^a   Torres, Orlando J M ^a   Beraldi, Rafael A ^b   Ribas, Carmen A P M ^b   Malafaia, Osvaldo ^b  

^a São Domingos Hospital   (Brazil)

^b HOSPITAL UNIVERSITÁRIO EVANGÉLICO DE CURITIBA   (Brazil)

Author keywords

Biomarker; Procalcitonin; Prognosis; Septic shock; Severe sepsis; SOFA score

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PLASMA CLEARANCE; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVOR; ADULT; AREA UNDER THE CURVE; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; MORTALITY; ORGAN DYSFUNCTION SCORE; SHOCK, SEPTIC; TIME;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SEPSIS; SHOCK, SEPTIC; SURVIVORS; TIME FACTORS;

EID: 84920593314     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.08.018     Document Type: Article

References (25)

1. Angus D.C., Linde-Zwirble W.T., Lidicker J., Clemont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001, 29(7):1303-1310.
2. Esper A.M., Martin G.S. Extending international sepsis epidemiology: the impact of organ dysfunction. Crit Care 2009, 13(1):120. 10.1186/cc7704.
3. Ranger-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., Wenzer R.P. The natural history of the systemic inflammatory response syndrome (SIRS): a prospective study. JAMA 1995, 273(2):117-123.
4. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000, 26:S64-S74.
5. Vincent J.L., Moreno R., Takala J., Suter P.M., Sprung C.L., Cotardyn F., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996, 22(7):707-710.
6. Moreno R., Vincent J.L., Matos R., Mendonça A., Cantraine F., Thijs L., et al. The use o maximum SOFA score to quantify organ dysfunction/failure in intensive care: results of a prospective, multicenter study. Intensive Care Med 1999, 25(7):686-696.
7. Jones A.E., Trzeciak S., Kline J.A. The sequential organ failure assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009, 37(5):1649-1654.
8. Ferreira F.L., Bota D.P., Bross A., Mélot C., Vincent J.L. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286(14):1754-1758.
9. Karlsson S., Heikkinen M., Pettila V., Alila S., Vaisanen S., Pulkk K., et al. Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study. Crit Care 2010, 14(6):R205. 10.1186/cc9327.
10. Shuetz P., Maurer P., Punjabi V., Desai A., Amin D.N., Gluck E. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients. Crit Care 2013, 17(3):R115. 10.1186/cc12787.
11. Jensen J.U., Heslet L., Jensen T.H., Espersen K., Steffensen P., Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006, 34(10):2596-2602.
12. Meng F.S., Su L., Tang Y.Q., Wen Q., Liu Y.S., Liu Z.F. Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem 2009, 42(3):1025-1031.
13. Claeys R., Vinken S., Spapen H., ver Elst K., Decochez K., Huyghens L., et al. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002, 30(4):757-762.
14. Guan J., Lin Z., Lue H. Dynamic change of procalcitonin, rather than concentration itself, is predictive of survival in septic shock patients when beyond 10 ng/ml. Shock 2011, 36(6):570-574.
15. Azevedo J.R., Torres O.J., Czeczko N.G., Tuon F.F., Nassif P.A., Souza G.D. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Rev Col Bras Cir 2012, 39(6):456-461.
16. Ruiz-Rodriguez J.C., Caballero J., Ruiz-Sanmartin A., Ribas V.J., Perez M., Bóveda J.L., et al. Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study. Med Intensiva 2012, 36(7):475-480.
17. Suberviola B., Castellanos-Ortega A., Gonzalez-Castro A., Garcia-Astudillo L.A., Fernandez-Miret B. Valor pronostico del aclaramiento de procalcitonina, PCR y leucocitos en el shock septico. Med Intensiva 2012, 36(3):177-184.
18. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580-637.
19. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31(4):1250-1256.
20. Azevedo J.R., Araujo L.O., da Silva W.S., Azevedo R.P. A carbohydrate-restrictive strategy is safer and as efficient as insulin therapy in critically ill patients. J Crit Care 2010, 25(1):84-89.
21. Raniere V.M., Thompson B.T., Barie P.S., Dhainaut J.F., Douglas I.S., Finfer S., et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012, 366(22):2055-2064.
22. Dahaba A.A., Hagara B., Fall A., Rehak P.H., List W.F., Metzler H. Procalcitonin for early survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006, 97(4):503-508.
23. Charles P.E., Tinel C., Barbar S., Aho S., Prin S., Doise J.M., et al. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 2009, 13(2):R38. 10.1186/cc7751.
24. Boussekey N., Leroy O., Alfandari S., Devos P., Georges H., Guery B. Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia. Intensive Care Med 2006, 32(3):469-472.
25. Meisner M., Schmidt J., Huttner H., Tshaikowski K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000, 26(Suppl. 2):S212-S216.